Product Program year 2024 Source: CMS Open Payments

Gallant

Device Cardiac Rhythm Management

PDI 05415067032003

Open in the dashboard

General payments

$264,160

5,444 payments

Research payments

$0

0 payments

Through program year 2024, $264,160 in general payments and $0 in research payments were reported against Gallant (Cardiac Rhythm Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $90,338 2,200
2023 General $121,766 2,525
2022 General $52,056 719

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $264,160 5,444 payments
Top recipients General payments · program year 2024
  1. Alexander Drtil Clinical Cardiac Electrophysiology · Houston, TX $5,730 6% · 10 payments
  2. David Burkland Clinical Cardiac Electrophysiology · Houston, TX $4,179 5% · 9 payments
  3. Farhan Majeed Interventional Cardiology · Port Charlotte, FL $1,988 2% · 8 payments
  4. Kevin Trulock Clinical Cardiac Electrophysiology · Indianapolis, IN $1,800 2% · 3 payments
  5. Catherine Mavroudis Surgery · Austin, TX $1,669 2% · 6 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Clinical Cardiac Electrophysiology Internal Medicine $33,617 38% · 332 practitioners
  2. Cardiovascular Disease Internal Medicine $19,465 22% · 297 practitioners
  3. Interventional Cardiology Internal Medicine $11,388 13% · 140 practitioners
  4. Internal Medicine $4,177 5% · 58 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $2,394 3% · 45 practitioners

The top 5 of 55 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Texas $25,162 28% · 169 recipients
  2. California $14,980 17% · 190 recipients
  3. Florida $8,891 10% · 122 recipients
  4. New York $7,273 8% · 89 recipients
  5. Indiana $3,522 4% · 12 recipients

The top 5 of 47 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

5,444 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record